Viralytics is investigating a range of coxsackievirus oncolytic virotherpeutics for cancer treatment due their targeted oncolytic activity. Coxsackieviruses A13, A15, A18, and A21 DAFv are all being investigated as potential therapeutics for cancer treatment.